(MedPage Today) — MADRID — Digitoxin added to guideline-directed medical therapy improved outcomes among patients with heart failure and reduced ejection fraction (HFrEF), the DIGIT-HF trial showed.
The cardiac glycoside reduced the primary…
Source link : https://www.medpagetoday.com/meetingcoverage/esc/117211
Author :
Publish date : 2025-08-29 09:30:00
Copyright for syndicated content belongs to the linked Source.
